Overview

The Effects of NOx and Conjugated Linoleic Acid on Asthmatics

Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This study will examine the hypothesis that in obese asthmatics; treatment with NOx + CLA is well tolerated, safe and will increase eNO while reducing airway oxidative stress. Allied with this, the investigators will define whether supplementing with this bioactive mediator modifies the airway microbiome, and reduces airway inflammation.
Phase:
Phase 2
Details
Lead Sponsor:
Gladwin, Mark, MD
University of Pittsburgh